Skip to main content
. 2017 Oct 18;7(11):e00849. doi: 10.1002/brb3.849

Table 1.

Clinical and demographic characteristics

Variables mRS 0–2 (= 191) mRS 3–6 (= 103) p value
Age 65 or older, n (%) 70 (36.6) 54 (52.4) .006
Male, n (%) 142 (74.3) 76 (73.8) .511
WBC (109/L) at admission 8.86 ± 3.41 9.07 ± 3.47 .459
RBC (1012/L) at admission 4.64 ± 0.50 4.64 ± 0.45 .843
Fibrinogen (g/L) at admission 2.85 ± 0.80 3.14 ± 1.08 .049
D‐Dimer (mg/L) at admission 1.26 ± 2.99 1.79 ± 2.57 .006
Blood glucose (mmol/L) 7.54 ± 3.38 8.92 ± 4.00 <.001
BUN at admission (mg/dl) 5.86 ± 1.83 6.13 ± 1.82 .282
Cr at admission (mg/dl) 71.00 ± 21.66 67.64 ± 17.76 .168
BUN/Cr at admission 18.20 ± 5.73 19.89 ± 6.10 .020
USG at admission 1.01 ± 0.01 1.02 ± 0.01 .002
Systolic blood pressure (mmHg) 152.31 ± 20.85 161.72 ± 22.33 .003
Diastolic blood pressure (mmHg) 87.37 ± 12.37 90.1 ± 12.02 .06
Dehydration status, n (%) 77 (40.3) 68 (66.0) .002
Hyperhomocysteinemia, n (%) 76 (39.8) 39 (37.9) .942
NIHSS at admission 6.98 ± 5.65 13.45 ± 8.11 <.001
Diabetes mellitus, n (%) 37 (19.4) 20 (19.4) .554
Hypertension, n (%) 99 (51.8) 63 (61.2) .079
Myocardial infarction, n (%) 19 (9.9) 7 (6.8) .248
Cerebral infarction, n (%) 39 (20.4) 25 (24.3) .267
Smoking, n (%) 88 (46.1) 38 (36.9) .081
Hyperlipidemia, n (%) 108 (58.1) 46 (45.5) .028
Blood glucose (mmol/L)
≤8 134 (72.0) 58 (56.3) .007
>8 52 (28.0) 45 (43.7)
Systolic pressure (mmHg)
≤150 176 (93.1) 87 (84.5) .018
>150 13 (6.9) 16 (15.5)
USG at admission
≤1.010 75 (39.3) 28 (27.2) .025
>1.010 116 (60.7) 75 (72.8)
BUN/Cr at admission
< 15 125 (65.4) 87 (84.5) .001
≥15 66 (34.6) 16 (15.5)
TOAST classification, N (%)
Large artery atherosclerosis 134 (70.2) 83 (80.6) .001
Small artery occlusion 36 (18.8) 5 (4.9)
Cardioembolism 10 (5.2) 14 (13.6)
Undetermined 11 (5.8) 1 (1.0)

WBC, white blood cell; RBC, red blood cell; BUN, blood urea nitrogen; NIHSS, National Institutes of Health stroke scale; TOAST, trial of org 10172 in acute stroke treatment.

Continuous data expressed as mean ± SD.